Results 1 to 6 of 6
Page 1 of 1
TypeTitleAuthor(s)YearViews
Screening of occult HBV infection in blood donors in Hong Kong using nucleic acid testingWong, DKH; Lai, CL; Fung, JYY; Lee, CK; Lin, CK; Hung, IFN; But, D; Hsu, A; Chan, P; Cheung, TK; Fung, FKC; Yuen, JCH; Young, JLP; Ngai, WS; Yuen, RMF2008167
 
One-year treatment of entecavir results in reduction in intrahepatic covalently closed circular DNA levelWong, DKH; Yuen, RMF; Ngai, WS; Kwok, CL; Lai, CL200571
 
Interim report on a phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in Chinese patients with chronic hepatitis B infectionYuen, RMF; Kim, J; Wong, DKH; Ngai, WS; Yuen, JCH; Lai, CL2004142
 
Interim report on a phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in Chinese patients with chronic hepatitis B infection.Yuen, RMF; Kim, J; Wong, DKH; Ngai, WS; Yuen, JCH; Lai, CL2004132
 
Phase I/II double-blind, randomized, placebo-controlled study of the novel anti-HBV agent LB80380/ANA380 in patients with chronic HBV infection.Yuen, RMF; Kim, J; Averett, D; Wong, DKH; Kim, CR; Kerr, B; Ngai, WS; Yuen, JCH; Lai, CL2004188
 
A phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in patients with chronic hepatitis B infectionYuen, RMF; Kim, J; Wong, DKH; Ngai, WS; Yuen, JCH; Lai, CL2003159
 
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download